Screener
10x Genomics, Inc. TXG Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s asset turnover?
- 10x Genomics, Inc. (TXG) reported asset turnover of 0.6× in Q2 2026.
- How has 10x Genomics, Inc.'s asset turnover changed year-over-year?
- 10x Genomics, Inc.'s asset turnover decreased by 9.1% year-over-year, from 0.7× to 0.6×.
- What is the long-term trend for 10x Genomics, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s asset turnover has grown at a 11.0% compound annual growth rate (CAGR), from 0.4× to 0.7×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about 10x Genomics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude